Physician profile
Ryan R Shake
NPI 1457707911
$1,239.02
in general payments reported to CMS, 2019-2025
8 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.91 · 2020: $29.79 · 2021: $129 · 2022: $344 · 2023: $296 · 2024: $132 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492 · Entertainment: $193 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.32 |
| Entertainment | $193.18 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $387.34 | 2021-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $308.70 | 2020-2025 | Precision7, Total30 |
| Coopervision INC. | $234.22 | 2022-2024 | Myday Contact Lens |
| Astellas Pharma US INC | $123.98 | 2025 | Izervay |
| Biotissue Holdings INC. | $72.71 | 2022 | |
| Bausch & Lomb Americas INC. | $58.82 | 2022-2025 | Miebo |
| Mallinckrodt Hospital Products INC. | $38.34 | 2022 | |
| Shire North American Group INC | $14.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Shake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.